FluoTech Biosciences Limited

REVOLUTIONIZING ACUTE CARE WITH NANOBIOTECH

Therapeutic Innovation: ATHRICINE Platform

Addressing Global Healthcare Challenges

The Cardiovascular Crisis:

19 Million Deaths

USD 146.5 billion Global cardio-therapeutics

80%

Residual risk despite current treatments

Our Solution: ATHRICINE Platform

It is a platform with:

Revolutionary drug delivery system

Enhanced therapeutic efficacy

Reduced side effects

Precise targeting capabilities

Cost-effective treatment approach

Manufacturing Excellence

Our advanced synthesis process ensures:

Consistent quality

Batch-to-batch reliability

Scalable production

Cost-effective manufacturing

Environmental sustainability

Safety and Biocompatibility

FTB-728 is designed with safety in mind:

Non-toxic components

Biodegradable structure

Minimal immune response

Controlled elimination

Environmental friendliness